Hesperidin, piperine and bee venom synergistically potentiate the anticancer effect of tamoxifen against breast cancer cells
Author:
Publisher
Elsevier BV
Subject
Pharmacology,General Medicine
Reference44 articles.
1. The global and regional burden of cancer;Forman,2014
2. Anti-cancer effects of Piper nigrum via inducing multiple molecular signaling in vivo and in vitro;Deng;J. Ethnopharmacol.,2016
3. Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen;Dowsett;J. Clin. Oncol.,2009
4. Five or more years of adjuvant endocrine therapy in breast cancer: a meta-analysis of published randomised trials;Petrelli;Breast Cancer Res. Treat.,2013
5. Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial;Davies;Lancet,2013
Cited by 84 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Synergistic enhancement: Exploring the potential of piperine in cancer therapeutics through chemosensitization and combination therapies;Life Sciences;2024-10
2. The anti-aromatase and anti-estrogenic activity of plant products in the treatment of estrogen receptor-positive breast cancer;The Journal of Steroid Biochemistry and Molecular Biology;2024-10
3. Piperine enhances doxorubicin sensitivity in triple-negative breast cancer by targeting the PI3K/Akt/mTOR pathway and cancer stem cells;Scientific Reports;2024-08-06
4. Chitosan nanoparticles, camel milk exosomes and/or Sorafenib induce apoptosis, inhibit tumor cells migration and angiogenesis and ameliorate the associated liver damage in Ehrlich ascites carcinoma-bearing mice;Beni-Suef University Journal of Basic and Applied Sciences;2024-08-02
5. Cytotoxic potential of Commicarpus plumbagineus extracts against liver cancer cell lines through In-Vitro and In-Silico methods;Journal of King Saud University - Science;2024-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3